Clinical implication of 14-3-3 epsilon expression in gastric cancer.
about
Proteomic analysis of cellular response induced by multi-walled carbon nanotubes exposure in A549 cellsDifferential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil.14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.A comparative proteomic study identified calreticulin and prohibitin up-regulated in adrenocortical carcinomas.Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.Overexpression of nuclear apoptosis-inducing factor 1 altered the proteomic profile of human gastric cancer cell MKN45 and induced cell cycle arrest at G1/S phase.Deregulated Expression of SRC, LYN and CKB Kinases by DNA Methylation and Its Potential Role in Gastric Cancer Invasiveness and MetastasisComparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancerWhat gastric cancer proteomic studies show about gastric carcinogenesis?YWHAE silencing induces cell proliferation, invasion and migration through the up-regulation of CDC25B and MYC in gastric cancer cells: new insights about YWHAE role in the tumor development and metastasis process.Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients.14-3-3ε is a nuclear matrix protein, and its altered expression and localization are associated with curcumin-induced apoptosis of MG-63 cells.HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
P2860
Q28394273-4CCEE7D1-AC0B-440F-AD9E-EF2CC05EFBCBQ31080548-6CCA39AD-0A5E-4A38-8931-3060D4EA132EQ34618508-D56EF715-CD7C-4A0C-A679-8A62BEC5D1D6Q34669541-56FFCAB0-C6AF-41D6-9300-DA8424693E30Q35143276-8E840BB1-3C70-4D93-9238-1ED2C2B6FE5CQ35187533-609ED554-680B-4F04-BEF0-798240A96126Q35804400-61E9A44D-9B25-49E7-9181-F5979B5D7295Q35827925-D2C8DE18-0525-49E2-A833-F79E15551889Q36002404-714257F6-6C04-43F8-8A1A-8DBC8EC6AC9BQ37709154-9E65C610-8C18-4B75-9339-92023FF6B22BQ38981782-5CD59671-D74E-4D98-8113-39D00E78DC3DQ44253238-8174A66C-5203-4DBE-A5EE-16F89FD05DBCQ47141913-3C0DF3C9-2CBE-47B4-A9AF-AF5F5C9A2187Q50354455-F9D42759-0D06-44A2-AE5B-6D9ABFD3B06C
P2860
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
@ast
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
@en
type
label
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
@ast
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
@en
prefLabel
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
@ast
Clinical implication of 14-3-3 epsilon expression in gastric cancer.
@en
P2093
P2860
P356
P1476
Clinical implication of 14-3-3 epsilon expression in gastric cancer
@en
P2093
Danielle Queiroz Calcagno
Paulo Pimentel Assumpção
Roger Chammas
Rommel Rodríguez Burbano
Sâmia Demachki
P2860
P304
P356
10.3748/WJG.V18.I13.1531
P407
P577
2012-04-01T00:00:00Z